SCHEMBL2210288

SCHEMBL2210288

CC(C)(C)c1ccc(NC(=O)[C@H]2CC[C@]3(CC2)CC(c2ccccc2)=NO3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.44
GLA P06280 1/20 0.43
ENPP3 O14638 3/20 0.41
ENPP1 P22413 3/20 0.41
ENPP2 Q13822 1/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
GFER P55789 1/20 0.41
NPY5R Q15761 1/20 0.41
MAPK1 P28482 1/20 0.40
HPGD P15428 1/20 0.39
FAAH O00519 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
CHRNB4 P30926 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205569 1.00 TRPV1 (0.44) TRPV1GLAENPP3ENPP1ENPP2
SCHEMBL2205560 1.00 TRPV1 (0.44) TRPV1GLAENPP3ENPP1ENPP2
SCHEMBL2211388 0.90 KMT2A (0.44) TRPV1ENPP3ENPP1ENPP2GAA
SCHEMBL2210139 0.87 MAPK10 (0.47) GLAGAAMAPTKMT2AMAPK1
SCHEMBL4618771 0.85 FAAH (0.41) MAPTFAAHCHRNB4CHRNA3KDM4E
SCHEMBL4619335 0.85 FAAH (0.41) MAPTFAAHCHRNB4CHRNA3KDM4E
SCHEMBL2208172 0.84 TRPV1 (0.45) TRPV1GLAENPP3ENPP1ENPP2
Hydrochloric Acid SCHEMBL2207446 0.83 TRPV1 (0.44) TRPV1GLAENPP3ENPP1ENPP2
SCHEMBL5130804 0.82 TRPV1 (0.53) TRPV1
SCHEMBL5015827 0.81 FAAH (0.43) TRPV1MAPTKMT2AFAAHCHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981883-B2 Substituted spiro-compounds and the use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-07-19 US claimed
US-20090275628-A1 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments GRUENENTHAL GMBH (DE) 2009-11-05 US claimed
US-7981883-B2 Substituted spiro-compounds and the use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-07-19 US disclosed
US-20090275628-A1 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments GRUENENTHAL GMBH (DE) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275628-A1 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments REN, PKD1, PKD2 TRPV1 649/4885GLA 777/4885ENPP3 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.